The association between cannabis use and suicidality among men and women: A population-based longitudinal study

Journal of Affective Disorders

Volumn 205, Issue , 2016, Pages 216-224

  Shalit, Nadav ^a,b   Shoval, Gal ^a,b   Shlosberg, Dan ^a,b   Feingold, Daniel ^c,d   Lev Ran, Shaul ^b,d  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ARIEL UNIVERSITY   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; AGED; ALCOHOLISM; ANHEDONIA; ANXIETY DISORDER; ARTICLE; CANNABIS USE; COMPARATIVE STUDY; CONTROLLED STUDY; DYSTHYMIA; FEMALE; HOUSEHOLD; HUMAN; HYPOMANIA; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; MIDDLE AGED; PERSONALITY DISORDER; PRIORITY JOURNAL; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; CANNABIS SMOKING; EPIDEMIOLOGY; ODDS RATIO; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX FACTORS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84989339606     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.07.010     Document Type: Article

References (96)

1. Agrawal, A., Lynskey, M.T., Cannabis controversies: how genetics can inform the study of comorbidity. Addiction 109 (2014), 360–370, 10.1111/add.12436.
2. Andreasson, S., Allebeck, P., Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scand. J. Soc. Med. 18 (1990), 9–15, 10.1177/140349489001800102.
3. Arseneault, L., Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 184 (2004), 110–117, 10.1192/bjp.184.2.110.
4. Baca-Garcia, E., Diaz-Sastre, C., Ceverino, A., Perez-Rodriguez, M.M., Navarro-Jimenez, R., Lopez-Castroman, J., Saiz-Ruiz, J., de Leon, J., Oquendo, M.A., Suicide attempts among women during low estradiol/low progesterone states. J. Psychiatr. Res. 44 (2010), 209–214, 10.1016/j.jpsychires.2009.08.004.
5. Baca-Garcia, E., Vaquero, C., Diaz-Sastre, C., Ceverino, A., Saiz-Ruiz, J., Fernández-Piquera, J., de Leon, J., A pilot study on a gene-hormone interaction in female suicide attempts. Eur. Arch. Psychiatry Clin. Neurosci. 253 (2003), 281–285, 10.1007/s00406-003-0441-6.
6. Baethge, C., Hennen, J., Khalsa, H.M.K., Salvatore, P., Tohen, M., Baldessarini, R.J., Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord. 10 (2008), 738–741, 10.1111/j.1399–5618.2007.00575.x.
7. Bartoli, F., Carrà, G., Brambilla, G., Carretta, D., Crocamo, C., Neufeind, J., Baldacchino, A., Humphris, G., Clerici, M., Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis. Drug Alcohol Depend. 134 (2014), 12–21, 10.1016/j.drugalcdep.2013.10.007.
8. Beautrais, A.L., Joyce, P.R., Mulder, R.T., Cannabis abuse and serious suicide attempts. Addiction 94 (1999), 1155–1164, 10.1046/j.1360–0443.1999.94811555.x.
9. Blanco, C., Hasin, D.S., Wall, M.M., Flórez-Salamanca, L., Hoertel, N., Wang, S., Kerridge, B.T., Olfson, M., Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiatry, 2016, 10.1001/jamapsychiatry.2015.3229.
10. Bolton, J.M., Robinson, J., Sareen, J., Self-medication of mood disorders with alcohol and drugs in the national epidemiologic survey on alcohol and related conditions. J. Affect. Disord. 115 (2009), 367–375, 10.1016/j.jad.2008.10.003.
11. Borges, G., Bagge, C.L., Orozco, R., A literature review and meta-analyses of cannabis use and suicidality. J. Affect. Disord. 195 (2016), 63–74, 10.1016/j.jad.2016.02.007.
12. Brown, T.T., Dobs, A.S., Endocrine effects of marijuana. J. Clin. Pharmacol. 42 (2002), 90S–96S, 10.1177/0091270002238799.
13. Carrà, G., Bartoli, F., Crocamo, C., Brady, K.T., Clerici, M., Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder. Bipolar Disord. 17 (2015), 113–114, 10.1111/bdi.12282.
14. Carrà, G., Bartoli, F., Crocamo, C., Brady, K.T., Clerici, M., Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. J. Affect. Disord. 167 (2014), 125–135, 10.1016/j.jad.2014.05.066.
15. Chabrol, H., Chauchard, E., Girabet, J., Cannabis use and suicidal behaviours in high-school students. Addict. Behav. 33 (2008), 152–155, 10.1016/j.addbeh.2007.04.029.
16. Chabrol, H., Melioli, T., Goutaudier, N., Cannabis use and suicidal ideations in high-school students. Addict. Behav. 39 (2014), 1766–1768, 10.1016/j.addbeh.2014.06.008.
17. Chatterji, S., Saunders, J.B., Vrasti, R., Grant, B.F., Hasin, D., Mager, D., Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule—alcohol/drug-revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 47 (1997), 171–185, 10.1016/S0376-8716(97)00088-4.
18. Chatzittofis, A., Nordström, P., Hellström, C., Arver, S., Åsberg, M., Jokinen, J., CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters. Eur. Neuropsychopharmacol. 23 (2013), 1280–1287, 10.1016/j.euroneuro.2013.02.002.
19. Chen, C.M., Yi, H., Dawson, D.A., Stinson, F.S., Grant, B.F., 2010. Alcohol use and alcohol use disorders in the United States, a 3-year follow-up: Main findings from the 2004–2005 wave 2 national epidemiologic survey on alcohol and related conditions (NESARC). US Alcohol Epidemiol. Data Ref. Man. 8.
20. Cottler, L.B., Grant, B.F., Blaine, J., Mavreas, V., Pull, C., Hasin, D., Compton, W.M., Rubio-Stipec, M., Mager, D., Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 47 (1997), 195–205, 10.1016/S0376-8716(97)00090-2.
21. Crane, N.A., Schuster, R.M., Fusar-Poli, P., Gonzalez, R., Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol. Rev. 23 (2014), 117–137, 10.1007/s11065-012-9222-1.Effects.
22. Crane, N.A., Schuster, R.M., Mermelstein, R.J., Gonzalez, R., Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. J. Clin. Exp. Neuropsychol. 37 (2015), 389–401, 10.1080/13803395.2015.1020770.
23. Degenhardt, L., Cheng, H., Anthony, J.C., Assessing cannabis dependence in community surveys: methodological issues. Int. J. Methods Psychiatr. Res. 16 (2007), 43–51, 10.1002/mpr.206.
24. Delforterie, M.J., Lynskey, M.T., Huizink, A.C., Creemers, H.E., Grant, J.D., Few, L.R., Glowinski, A.L., Statham, D.J., Trull, T.J., Bucholz, K.K., Madden, P.A.F., Martin, N.G., Heath, A.C., Agrawal, A., The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend. 150 (2015), 98–104, 10.1016/j.drugalcdep.2015.02.019.
25. Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T.R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S.A., Wiffen, B., Powell, J., Murray, R.M., High-potency cannabis and the risk of psychosis. Br. J. Psychiatry 195 (2009), 488–491, 10.1192/bjp.bp.109.064220.
26. Donovan, J.E., Jessor, R., Costa, F.M., Adolescent health behavior and conventionality-unconventionality: An extension of problem behavior theory. Health Psychol, 1991.
27. Fattore, L., Fratta, W., How important are sex differences in cannabinoid action. Br. J. Pharmacol. 160 (2010), 544–548, 10.1111/j.1476–5381.2010.00776.x.
28. Feingold, D., Weiser, M., Rehm, J., Lev-Ran, S., The association between cannabis use and mood disorders: a longitudinal study. J. Affect. Disord. 172 (2015), 211–218, 10.1016/j.jad.2014.10.006.
29. Feingold, D., Weiser, M., Rehm, J., Lev-Ran, S., The association between cannabis use and anxiety disorders: Results from a population-based representative sample. Eur. Neuropsychopharmacol. 26 (2015), 493–505, 10.1016/j.euroneuro.2015.12.037.
30. Fergusson, D.M., Beautrais, a L., Horwood, L.J., Vulnerability and resiliency to suicidal behaviours in young people. Psychol. Med, 33, 2003, 61–73, 10.1017/S0033291702006748.
31. Fergusson, D.M., Horwood, L.J., Lynskey, M.T., The comorbidities of adolescent problem behaviors: a latent class model. J. Abnorm. Child. Psychol. 22 (1994), 339–354, 10.1007/BF02168078.
32. Frank, E., Gender and Its effects on psychopathology. J. Chem. Inf. Model. Am. Psychopathol. Assoc., 2000, 10.1017/CBO9781107415324.004.
33. Galea, S., Ahern, J., Tracy, M., Vlahov, D., Neighborhood income and income distribution and the use of cigarettes, alcohol, and marijuana. Am. J. Prev. Med. 32 (2007), S195–S202, 10.1016/j.amepre.2007.04.003.
34. Grant, B.F., Dawson, D.A., Stinson, F.S., Chou, P.S., Kay, W., Pickering, R., The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 71 (2003), 7–16, 10.1016/S0376-8716(03)00070-X.
35. Grant, B.F., Kaplan, K.D., 2005. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). National Institute on Alcohol Abuse and Alcoholism, Rockville, MD:.
36. Grant, B.F., Moore, T.C., Shepard, J., Kaplan, K., 2003b. Source and accuracy statement: wave 1 national epidemiologic survey on alcohol and related conditions (NESARC). National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
37. Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., Pickering, R.P., Kaplan, K., Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61 (2004), 807–816, 10.1001/archpsyc.61.8.807.
38. Hasin, D., The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 44 (1997), 133–141, 10.1016/S0376-8716(97)01332-X.
39. Hays, R.D., Ellickson, P.L., Associations between drug use and devient behavior in teenagers. Addict. Behav. 21 (1996), 291–302.
40. Hicks, B.M., Schalet, B.D., Malone, S.M., Iacono, W.G., McGue, M., Psychometric and genetic architecture of substance use disorder and behavioral disinhibition measures for gene association studies. Behav. Genet. 41 (2011), 459–475, 10.1007/s10519-010-9417-2.
41. Hoertel, N., Franco, S., Wall, M.M., Oquendo, M. a, Kerridge, B.T., Limosin, F., Blanco, C., Mental disorders and risk of suicide attempt: a national prospective study. Mol. Psychiatry 20 (2015), 718–726, 10.1038/mp.2015.19.
42. Hungund, B.L., Vinod, K.Y., Kassir, S.A., Basavarajappa, B.S., Yalamanchili, R., Cooper, T.B., Mann, J.J., Arango, V., Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol. Psychiatry 9 (2004), 184–190, 10.1038/sj.mp.4001376.
43. Kendall, D.A., Stancel, G.M., Enna, S.J., The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J. Neurosci. 2 (1982), 354–360.
44. Kessler, R.C., Borges, G., Walters, E.E., Prevalence of and risk factors for lifetime suicide attempts in the national comorbidity survey. Arch. Gen. Psychiatry, 56, 1999, 617, 10.1001/archpsyc.56.7.617.
45. Khantzian, E.J., The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 4 (1997), 231–244, 10.3109/10673229709030550.
46. Kidd, S.A., The need for improved operational definition of suicide attempts : illustrations from the case of street youth. Death Stud., 2003, 449–456, 10.1080/07481180302877.
47. Kim, B., Kang, E.-S., Fava, M., Mischoulon, D., Soskin, D., Yu, B.-H., Lee, D., Lee, D.-Y., Park, H.-D., Jeon, H.J., Follicle-stimulating hormone (FSH), current suicidal ideation and attempt in female patients with major depressive disorder. Psychiatry Res. 210 (2013), 951–956, 10.1016/j.psychres.2013.08.057.
48. Kohn, L., Kittel, F., Piette, D., Peer, family integration and other determinants of cannabis use among teenagers. Int. J. Adolesc. Med. Health 16 (2004), 359–370, 10.1515/IJAMH.2004.16.4.359.
49. Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., Miettunen, J., Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 36 (2010), 1115–1130, 10.1093/schbul/sbp031.
50. Krueger, R.F., Hicks, B.M., Patrick, C.J., Carlson, S.R., Iacono, W.G., McGue, M., Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J. Abnorm. Psychol., 2002, 10.1037/0021-843X.111.3.411.
51. Leventhal, T., Brooks-Gunn, J., The neighborhoods they live in: the effects of neighborhood residence on child and adolescent outcomes. Psychol. Bull. 126 (2000), 309–337, 10.1037/0033–2909.126.2.309.
52. Lev-Ran, S., Imtiaz, S., Le Foll, B., Self-reported psychotic disorders among Individuals with substance use disorders: findings from the national epidemiologic survey on alcohol and related conditions. Am. J. Addict. 21 (2012), 531–535, 10.1111/j.1521–0391.2012.00283.x.
53. Lev-Ran, S., Roerecke, M., Le Foll, B., George, T.P., McKenzie, K., Rehm, J., The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. 44 (2014), 797–810, 10.1017/S0033291713001438.
54. Linehan, M.M., Suicidal people: one population or two?. Ann. N. Y. Acad. Sci. 487 (1986), 16–33, 10.1111/nyas.1986.487.issue-1.
55. Lisdahl, K.M., Gilbart, E.R., Wright, N.E., Shollenbarger, S., Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front. Psychiatry 4 (2013), 1–19, 10.3389/fpsyt.2013.00053.
56. Lynskey, M.T., Glowinski, A.L., Todorov, A. a, Bucholz, K.K., Madden, P. a F., Nelson, E.C., Statham, D.J., Martin, N.G., Heath, A.C., Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch. Gen. Psychiatry 61 (2004), 1026–1032, 10.1016/S0084-3970(08)70083-5.
57. Maharajh, H.D., Konings, M., Cannabis and suicidal behaviour among adolescents: a pilot study from Trinidad. Sci. World J. 5 (2005), 576–585, 10.1100/tsw.2005.79.
58. Maria, M.M.M.-S., Flanagan, J., Brady, K., Ovarian hormones and drug abuse. Curr. Psychiatry Rep., 16, 2014, 511, 10.1007/s11920-014-0511-7.
59. Marusich, J.A., Craft, R.M., Lefever, T.W., Wiley, J.L., The impact of gonadal hormones on cannabinoid dependence. Exp. Clin. Psychopharmacol. 23 (2015), 206–216, 10.1037/pha0000027.
60. McDonald, J., Schleifer, L., Richards, J.B., de Wit, H., Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28 (2003), 1356–1365, 10.1038/sj.npp.1300176.
61. Meyer, R.E., Salzman, C., Youngstrom, E.A., Clayton, P.J., Goodwin, F.K., Mann, J.J., Alphs, L.D., Broich, K., Goodman, W.K., Greden, J.F., Meltzer, H.Y., Normand, S.L.T., Posner, K., Shaffer, D., Oquendo, M.A., Stanley, B., Trivedi, M.H., Turecki, G., Beasley, C.M., Beautrais, A.L., Bridge, J.A., Brown, G.K., Revicki, D.A., Ryan, N.D., Sheehan, D.V., Suicidality and risk of suicide - Definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J. Clin. Psychiatry, 2010, 71, 10.4088/JCP.10cs06070blu.
62. Moore, T.H.M., Zammit, S., Lingford-Hughes, A., Barnes, T.R.E., Jones, P.B., Burke, M., Lewis, G., Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370 (2007), 319–328, 10.1016/S0140-6736(07)61162-3.
63. Morgan, C.J.A., Curran, H.V., Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br. J. Psychiatry 192 (2008), 306–307, 10.1192/bjp.bp.107.046649.
64. Mousavi, S.G., Bateni, S., Maracy, M.R., Mardanian, F., Mousavi, S.H., Recurrent suicide attempt and female hormones. Adv. Biomed. Res., 3, 2014, 201, 10.4103/2277–9175.142046.
65. Murphy, L.L., Muñoz, R.M., Adrian, B.A., Villanúa, M.A., Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis. 5 (1998), 432–446, 10.1006/nbdi.1998.0224.
66. Pae, C.-U., Mandelli, L., Kim, T.-S., Han, C., Masand, P.S., Marks, D.M., Patkar, A. a, Steffens, D.C., De Ronchi, D., Serretti, A., Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed. Pharmacother. 63 (2009), 228–235, 10.1016/j.biopha.2008.03.010.
67. Pallis, D.J., Holding, T.A., The menstrual cycle and suicidal intent. J. Biosoc. Sci. 8 (2008), 27–33, 10.1017/S0021932000010427.
68. Palmer, B.A., Pankratz, V.S., Bostwick, J.M., The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry 62 (2005), 247–253, 10.1001/archpsyc.62.3.247.
69. Pedersen, W., Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatr. Scand. 118 (2008), 395–403, 10.1111/j.1600–0447.2008.01259.x.
70. Price, C., Hemmingsson, T., Lewis, G., Zammit, S., Allebeck, P., Cannabis and suicide: longitudinal study. Br. J. Psychiatry 195 (2009), 492–497, 10.1192/bjp.bp.109.065227.
71. Pull, C.B., Saunders, J.B., Mavreas, V., Cottler, L.B., Grant, B.F., Hasin, D.S., Blaine, J., Marger, D., Ustun, B.T., Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend. 47 (1997), 207–216, 10.1016/S0376-8716(97)00091-4.
72. Raphael, B., Wooding, S., Stevens, G., Connor, J., Comorbidity: cannabis and complexity. J. Psychiatr. Pract. 11 (2005), 161–176, 10.1097/00131746-200505000-00004.
73. Rasic, D., Weerasinghe, S., Asbridge, M., Langille, D.B., Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend. 129 (2013), 49–53, 10.1016/j.drugalcdep.2012.09.009.
74. Rice, T.R., Sher, L., Adolescent suicide and testosterone. Int. J. Adolesc. Med. Health, 2015, 10.1515/ijamh-2015–0058.
75. Schweinsburg, A.D., Brown, S.A., Tapert, S.F., The influence of marijuana use on neurocognitive functioning in adolescents. Curr. Drug Abus. Rev. 1 (2008), 99–111, 10.2174/1874473710801010099.
76. Silins, E., Horwood, L.J., Patton, G.C., Fergusson, D.M., Olsson, C.A., Hutchinson, D.M., Spry, E., Toumbourou, J.W., Degenhardt, L., Swift, W., Coffey, C., Tait, R.J., Letcher, P., Copeland, J., Mattick, R.P., Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry 1 (2014), 286–293, 10.1016/S2215-0366(14)70307-4.
77. Stinson, F.S., Ruan, W.J., Pickering, R., Grant, B.F., Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol. Med. 36 (2006), 1447–1460, 10.1017/S0033291706008361.
78. Sznitman, S.R., Bretteville-Jensen, A.L., Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. Harm Reduct. J., 12, 2015, 46, 10.1186/s12954-015-0082-x.
79. Sznitman, S.R., Lewis, N., Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage. Int. J. Drug Policy 26 (2015), 446–452, 10.1016/j.drugpo.2015.01.010.
80. Tu, A.W., Ratner, P. a, Johnson, J.L., Gender differences in the correlates of adolescents’ cannabis use. Subst. Use Misuse 43 (2008), 1438–1463, 10.1080/10826080802238140.
81. United Nations Office on Drugs and Crime, World Drug Report 2015 (United Nations publication, Sales No. E.15.XI.6), ISBN: 978-92-1-148282-9; eISBN: 978-92-1-057300-9.
82. Usall, J., Pinto-Meza, A., Fern??ndez, A., Graaf, R. de, Demyttenaere, K., Alonso, J., Girolamo, G. de, Lepine, J.P., Kovess, V., Haro, J.M., Suicide ideation across reproductive life cycle of women results from a European epidemiological study. J. Affect. Disord. 116 (2009), 144–147, 10.1016/j.jad.2008.12.006.
83. van Laar, M., van Dorsselaer, S., Monshouwer, K., de Graaf, R., Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?. Addiction 102 (2007), 1251–1260, 10.1111/j.1360–0443.2007.01875.x.
84. van Ours, J.C., Williams, J., Ferguson, D., Horwood, L.J., Fergusson, D., Horwood, L.J., Cannabis use and suicidal ideation. J. Health Econ. 32 (2013), 524–537, 10.1016/j.jhealeco.2013.02.002.
85. Vinod, K.Y., Role of the endocannabinoid system in the neurobiology of suicide. Dwivedi, Y., (eds.) The neurological basis of suicide, 2012, CRC Press/Taylor & Francis, Boca Raton, FL, USA.
86. Vinod, K.Y., Arango, V., Xie, S., Kassir, S.A., Mann, J.J., Cooper, T.B., Hungund, B.L., Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol. Psychiatry 57 (2005), 480–486, 10.1016/j.biopsych.2004.11.033.
87. Vinod, K.Y., Hungund, B.L., Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27 (2006), 539–545, 10.1016/j.tips.2006.08.006.
88. Vinod, K.Y., Kassir, S.A., Hungund, B.L., Cooper, T.B., Mann, J.J., Arango, V., Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J. Psychiatr. Res. 44 (2010), 591–597, 10.1016/j.jpsychires.2009.11.013.
89. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R.B., Adverse health effects of marijuana use. N. Engl. J. Med. 370 (2014), 2219–2227, 10.1056/NEJMra1402309.
90. Volkow, N.D., Swanson, J.M., Evins, A.E., DeLisi, L.E., Meier, M.H., Gonzalez, R., Bloomfield, M.A.P., Curran, H.V., Baler, R., Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry, 2016, 1–6, 10.1001/jamapsychiatry.2015.3278.
91. Vrasti, R., Grant, B.F., Chatterji, S., Üstün, B.T., Mager, D., Olteanu, I., Badoi, M., Reliability of the Romanian version of the alcohol module of the WHO alcohol use disorder and associated disabilities: interview schedule - alcohol/drug-revised. Eur. Addict. Res. 4 (1998), 144–149, 10.1159/000018947.
92. Welberg, L., Addiction: pregnenolone limits effects of cannabis. Nat. Rev. Neurosci. 15 (2014), 66–67, 10.1038/nrn3681.
93. Wilcox, H.C., Conner, K.R., Caine, E.D., Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend. 76 (2004), S11–S19, 10.1016/j.drugalcdep.2004.08.003.
94. Wunderlich, U., Bronisch, T., Wittchen, H.-U., Carter, R., Gender differences in adolescents and young adults with suicidal behavior. Acta Psychiatr. Scand. 104 (2001), 332–339, 10.1111/j.1600–0447.2001.00432.x.
95. Zhang, J., Jia, C.-X., Wang, L.-L., Testosterone differs between suicide attempters and community controls in men and women of China. Physiol. Behav. 141 (2015), 40–45, 10.1016/j.physbeh.2015.01.004.
96. Zhang, X., Wu, L.-T., Suicidal ideation and substance use among adolescents and young adults: a bidirectional relation?. Drug Alcohol Depend., 2014, 63–73, 10.1016/j.drugalcdep.2014.05.025.